LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

Robert Frost by Robert Frost
April 4, 2025
in Industries
Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. 

Reuters

President Donald Trump on Friday dropped a Biden administration proposal to have Medicare cover obesity drugs, including popular but costly GLP-1 treatments such as Novo Nordisk‘s Wegovy and Eli Lilly‘s Zepbound.

But the Centers for Medicare and Medicaid Services said it may reconsider coverage of those drugs in the future, according to a fact sheet on the rule.

The proposal would have given millions more Americans access to those drugs, but would have cost the government billions. Many health plans, including Medicare, don’t currently cover weight loss treatments, and some patients simply can’t afford their hefty price tags before insurance.

Wegovy and Zepbound both cost roughly $1,000 before insurance and other rebates. Allowing Medicare to cover those drugs and other weight loss medications could cost $35 billion over nine years, a congressional analysis found.

Under the Biden administration’s proposal, only those who are considered obese — someone who has a body mass index of 30 or higher — would qualify for coverage. Some people may already get coverage of the drugs through Medicare or Medicaid if they have diabetes or are at risk for stroke or heart disease.

The rule wasn’t finalized before Trump took office.

Novo Nordisk and Eli Lilly did not immediately respond to requests for comment.

Shares of Lilly fell more than 2% in extended trading, while Novo Nordisk’s stock dropped more than 1%.

You might also like

UnitedHealth says it is facing DOJ investigation over Medicare billing practices

Tesla Autopilot less safe, Optimus freezes, electric Mustang goes 250,000 miles

91% of renewables are cheaper than fossil fuels, but Trump just defunded a vital US grid upgrade



Source link

Share30Tweet19
Previous Post

Mikel Arteta reveals ‘uncertainty’ that could complicate Arsenal transfers

Next Post

SEC lays out guidelines for stablecoins, excludes algorithmic tokens

Robert Frost

Robert Frost

Jutawantoto Jutawantoto Jutawantoto Jutawantoto Berita Terbaru Hari

Recommended For You

UnitedHealth says it is facing DOJ investigation over Medicare billing practices
Industries

UnitedHealth says it is facing DOJ investigation over Medicare billing practices

July 24, 2025
Tesla Autopilot less safe, Optimus freezes, electric Mustang goes 250,000 miles
Industries

Tesla Autopilot less safe, Optimus freezes, electric Mustang goes 250,000 miles

July 24, 2025
91% of renewables are cheaper than fossil fuels, but Trump just defunded a vital US grid upgrade
Industries

91% of renewables are cheaper than fossil fuels, but Trump just defunded a vital US grid upgrade

July 23, 2025
Elon Musk with a straight face: Tesla Robotaxi will cover half of US population by end of the year
Industries

Elon Musk with a straight face: Tesla Robotaxi will cover half of US population by end of the year

July 23, 2025
Next Post
SEC lays out guidelines for stablecoins, excludes algorithmic tokens

SEC lays out guidelines for stablecoins, excludes algorithmic tokens

Related News

Dick’s Sporting Goods’ stock rallies in premarket after it boosts its 2023 profit outlook

Dick’s Sporting Goods’ stock rallies in premarket after it boosts its 2023 profit outlook

November 21, 2023
New Tesla Model Y vehicles with design refresh spotted in China

New Tesla Model Y vehicles with design refresh spotted in China

October 25, 2024
Global energy giant RWE halts US offshore wind because of Trump

Global energy giant RWE halts US offshore wind because of Trump

April 26, 2025

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?